TheStreet's Jim Cramer and Marc Chaikin, of Chaikin Analytics, spent an hour together at our offices talking all things markets. Listen to the whole conversation below. In the except above, they discuss Allergan and why you can't trade it.
It's not often you get two powerhouses to sit down and discuss their investing strategies, hottest stocks picks, earnings, the economy and more. Investors of any age can learn from this powerful one hour conversation with TheStreet's Jim Cramer and Marc Chaikin of Chaikin Analytics.
In the video above, they tackle Allergan (AGN) (also in Jim Cramer's AAP portfolio). Cramer actually looks to Chaikin for advice on the stock.
"You can't trade them," says Chaikin, referring to not just Allergan, but all the big biotechs.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.
Email
Email sent
Thank you, your email to has been sent successfully.
